Christopher Gallen

Christopher Gallen

Voorzitter bij
Treos Bio Ltd.
74 jaar
Health Technology
Commercial Services
Consumer Services

Profiel

Christopher C.
Gallen
is Chairman at Treos Bio Ltd. since 2026.
Former positions include President & Chief Executive Officer at Neuromed Pharmaceuticals, Inc. in 2010 and at Neuromed Pharmaceuticals Ltd. from 2004 to 2010; Senior Director-Medical & Scientific Services at Quintiles International Clinical Research Corp.
in 1995; Vice President-Research & Development at CombinatoRx, Inc. in 2010; President-Clinical Research Organization Division at Premier Research Worldwide in 1998; Chief of Operations & Clinical Research at Wyeth Research from 2002 to 2011; Vice President-Clinical Research at Pharmacia, Inc.; and Executive Vice President-Research & Development at Zalicus, Inc. from 2010 to 2012.
Education includes a doctorate from Emory University and an undergraduate degree from the University of Florida.

Actieve functies van Christopher Gallen

BedrijvenFunctieBegin
Voorzitter 28-05-2026

Eerdere bekende functies van Christopher Gallen

BedrijvenFunctieEinde
Hoofd Techniek/Wetenschap/O&O 01-03-2012
President 07-01-2010
President 27-01-2010
President 27-01-2010
Corporate Officer/Principal 01-12-1998
Ervaring van Christopher Gallen in detail bekijken

Opleiding van Christopher Gallen

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

28

Eerstegraads connecties

11

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit11

Health Technology

Health Technology

Commercial Services

Consumer Services

Consumer Services

Health Technology

Commercial Services

Pharmacia, Inc.

Health Technology

Quintiles International Clinical Research Corp.

Commercial Services

  1. Beurs
  2. Insiders
  3. Christopher Gallen